Veranika Razhkova is an Analyst on the Biotherapeutics group at Deerfield and joined the Firm in 2015 as a Fellow. She provides extensive research and analysis on early-stage investments. Prior to joining the Biotherapeutics group, Ms. Razhkova worked on patient forecasting in the Deerfield Institute. She holds a B.A. in Natural Sciences from The City University of New York’s Baruch College and M.S. in Biotechnology from Johns Hopkins University.